Global Type 2 Diabetes Medication Market Size, Status and Forecast 2024-2031

Report ID: 923151 | Published Date: Jan 2025 | No. of Page: 115 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Biguanides
        1.2.3 Sulphonylureas
        1.2.4 Thiazolidinediones
        1.2.5 Alpha-glucosidase Inhibitors
        1.2.6 DPP-4 Inhibitors
        1.2.7 GLP-1 Receptor Agonists
        1.2.8 SGLT-2 Inhibitors
        1.2.9 Insulins
    1.3 Market by Application
        1.3.1 Global Type 2 Diabetes Medication Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Type 2 Diabetes Medication Market Perspective (2016-2027)
    2.2 Type 2 Diabetes Medication Growth Trends by Regions
        2.2.1 Type 2 Diabetes Medication Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Type 2 Diabetes Medication Historic Market Share by Regions (2016-2021)
        2.2.3 Type 2 Diabetes Medication Forecasted Market Size by Regions (2022-2027)
    2.3 Type 2 Diabetes Medication Industry Dynamic
        2.3.1 Type 2 Diabetes Medication Market Trends
        2.3.2 Type 2 Diabetes Medication Market Drivers
        2.3.3 Type 2 Diabetes Medication Market Challenges
        2.3.4 Type 2 Diabetes Medication Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Type 2 Diabetes Medication Players by Revenue
        3.1.1 Global Top Type 2 Diabetes Medication Players by Revenue (2016-2021)
        3.1.2 Global Type 2 Diabetes Medication Revenue Market Share by Players (2016-2021)
    3.2 Global Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Type 2 Diabetes Medication Revenue
    3.4 Global Type 2 Diabetes Medication Market Concentration Ratio
        3.4.1 Global Type 2 Diabetes Medication Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medication Revenue in 2020
    3.5 Type 2 Diabetes Medication Key Players Head office and Area Served
    3.6 Key Players Type 2 Diabetes Medication Product Solution and Service
    3.7 Date of Enter into Type 2 Diabetes Medication Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Type 2 Diabetes Medication Breakdown Data by Type
    4.1 Global Type 2 Diabetes Medication Historic Market Size by Type (2016-2021)
    4.2 Global Type 2 Diabetes Medication Forecasted Market Size by Type (2022-2027)

5 Type 2 Diabetes Medication Breakdown Data by Application
    5.1 Global Type 2 Diabetes Medication Historic Market Size by Application (2016-2021)
    5.2 Global Type 2 Diabetes Medication Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Type 2 Diabetes Medication Market Size (2016-2027)
    6.2 North America Type 2 Diabetes Medication Market Size by Type
        6.2.1 North America Type 2 Diabetes Medication Market Size by Type (2016-2021)
        6.2.2 North America Type 2 Diabetes Medication Market Size by Type (2022-2027)
        6.2.3 North America Type 2 Diabetes Medication Market Size by Type (2016-2027)
    6.3 North America Type 2 Diabetes Medication Market Size by Application
        6.3.1 North America Type 2 Diabetes Medication Market Size by Application (2016-2021)
        6.3.2 North America Type 2 Diabetes Medication Market Size by Application (2022-2027)
        6.3.3 North America Type 2 Diabetes Medication Market Size by Application (2016-2027)
    6.4 North America Type 2 Diabetes Medication Market Size by Country
        6.4.1 North America Type 2 Diabetes Medication Market Size by Country (2016-2021)
        6.4.2 North America Type 2 Diabetes Medication Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Type 2 Diabetes Medication Market Size (2016-2027)
    7.2 Europe Type 2 Diabetes Medication Market Size by Type
        7.2.1 Europe Type 2 Diabetes Medication Market Size by Type (2016-2021)
        7.2.2 Europe Type 2 Diabetes Medication Market Size by Type (2022-2027)
        7.2.3 Europe Type 2 Diabetes Medication Market Size by Type (2016-2027)
    7.3 Europe Type 2 Diabetes Medication Market Size by Application
        7.3.1 Europe Type 2 Diabetes Medication Market Size by Application (2016-2021)
        7.3.2 Europe Type 2 Diabetes Medication Market Size by Application (2022-2027)
        7.3.3 Europe Type 2 Diabetes Medication Market Size by Application (2016-2027)
    7.4 Europe Type 2 Diabetes Medication Market Size by Country
        7.4.1 Europe Type 2 Diabetes Medication Market Size by Country (2016-2021)
        7.4.2 Europe Type 2 Diabetes Medication Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Type 2 Diabetes Medication Market Size (2016-2027)
    8.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type
        8.2.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2016-2027)
    8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Application
        8.3.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2016-2027)
    8.4 Asia-Pacific Type 2 Diabetes Medication Market Size by Region
        8.4.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Type 2 Diabetes Medication Market Size (2016-2027)
    9.2 Latin America Type 2 Diabetes Medication Market Size by Type
        9.2.1 Latin America Type 2 Diabetes Medication Market Size by Type (2016-2021)
        9.2.2 Latin America Type 2 Diabetes Medication Market Size by Type (2022-2027)
        9.2.3 Latin America Type 2 Diabetes Medication Market Size by Type (2016-2027)
    9.3 Latin America Type 2 Diabetes Medication Market Size by Application
        9.3.1 Latin America Type 2 Diabetes Medication Market Size by Application (2016-2021)
        9.3.2 Latin America Type 2 Diabetes Medication Market Size by Application (2022-2027)
        9.3.3 Latin America Type 2 Diabetes Medication Market Size by Application (2016-2027)
    9.4 Latin America Type 2 Diabetes Medication Market Size by Country
        9.4.1 Latin America Type 2 Diabetes Medication Market Size by Country (2016-2021)
        9.4.2 Latin America Type 2 Diabetes Medication Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Type 2 Diabetes Medication Market Size (2016-2027)
    10.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type
        10.2.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2016-2027)
    10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Application
        10.3.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2016-2027)
    10.4 Middle East & Africa Type 2 Diabetes Medication Market Size by Country
        10.4.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Type 2 Diabetes Medication Introduction
        11.1.4 AstraZeneca Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.1.5 AstraZeneca Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Type 2 Diabetes Medication Introduction
        11.2.4 Novartis Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Type 2 Diabetes Medication Introduction
        11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.3.5 Novo Nordisk Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Type 2 Diabetes Medication Introduction
        11.4.4 Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Introduction
        11.5.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Details
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.6.5 Bristol-Myers Squibb Recent Development
    11.7 Eli Lilly
        11.7.1 Eli Lilly Company Details
        11.7.2 Eli Lilly Business Overview
        11.7.3 Eli Lilly Type 2 Diabetes Medication Introduction
        11.7.4 Eli Lilly Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.7.5 Eli Lilly Recent Development
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Type 2 Diabetes Medication Introduction
        11.8.4 Merck Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.8.5 Merck Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Type 2 Diabetes Medication Introduction
        11.9.4 Sanofi Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.9.5 Sanofi Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Type 2 Diabetes Medication Introduction
        11.10.4 Pfizer Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.10.5 Pfizer Recent Development
    11.11 Astellas Pharma
        11.11.1 Astellas Pharma Company Details
        11.11.2 Astellas Pharma Business Overview
        11.11.3 Astellas Pharma Type 2 Diabetes Medication Introduction
        11.11.4 Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.11.5 Astellas Pharma Recent Development
    11.12 Daiichi Sankyo
        11.12.1 Daiichi Sankyo Company Details
        11.12.2 Daiichi Sankyo Business Overview
        11.12.3 Daiichi Sankyo Type 2 Diabetes Medication Introduction
        11.12.4 Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.12.5 Daiichi Sankyo Recent Development
    11.13 Biocon
        11.13.1 Biocon Company Details
        11.13.2 Biocon Business Overview
        11.13.3 Biocon Type 2 Diabetes Medication Introduction
        11.13.4 Biocon Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.13.5 Biocon Recent Development
    11.14 Glenmark
        11.14.1 Glenmark Company Details
        11.14.2 Glenmark Business Overview
        11.14.3 Glenmark Type 2 Diabetes Medication Introduction
        11.14.4 Glenmark Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.14.5 Glenmark Recent Development
    11.15 Bayer AG
        11.15.1 Bayer AG Company Details
        11.15.2 Bayer AG Business Overview
        11.15.3 Bayer AG Type 2 Diabetes Medication Introduction
        11.15.4 Bayer AG Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.15.5 Bayer AG Recent Development
    11.16 Takeda
        11.16.1 Takeda Company Details
        11.16.2 Takeda Business Overview
        11.16.3 Takeda Type 2 Diabetes Medication Introduction
        11.16.4 Takeda Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.16.5 Takeda Recent Development
    11.17 Sun pharma
        11.17.1 Sun pharma Company Details
        11.17.2 Sun pharma Business Overview
        11.17.3 Sun pharma Type 2 Diabetes Medication Introduction
        11.17.4 Sun pharma Revenue in Type 2 Diabetes Medication Business (2016-2021)
        11.17.5 Sun pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Type 2 Diabetes Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Biguanides
    Table 3. Key Players of Sulphonylureas
    Table 4. Key Players of Thiazolidinediones
    Table 5. Key Players of Alpha-glucosidase Inhibitors
    Table 6. Key Players of DPP-4 Inhibitors
    Table 7. Key Players of GLP-1 Receptor Agonists
    Table 8. Key Players of SGLT-2 Inhibitors
    Table 9. Key Players of Insulins
    Table 10. Global Type 2 Diabetes Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Type 2 Diabetes Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 12. Global Type 2 Diabetes Medication Market Size by Regions (2016-2021) & (US$ Million)
    Table 13. Global Type 2 Diabetes Medication Market Share by Regions (2016-2021)
    Table 14. Global Type 2 Diabetes Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 15. Global Type 2 Diabetes Medication Market Share by Regions (2022-2027)
    Table 16. Type 2 Diabetes Medication Market Trends
    Table 17. Type 2 Diabetes Medication Market Drivers
    Table 18. Type 2 Diabetes Medication Market Challenges
    Table 19. Type 2 Diabetes Medication Market Restraints
    Table 20. Global Type 2 Diabetes Medication Revenue by Players (2016-2021) & (US$ Million)
    Table 21. Global Type 2 Diabetes Medication Market Share by Players (2016-2021)
    Table 22. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes Medication as of 2020)
    Table 23. Ranking of Global Top Type 2 Diabetes Medication Companies by Revenue (US$ Million) in 2020
    Table 24. Global 5 Largest Players Market Share by Type 2 Diabetes Medication Revenue (CR5 and HHI) & (2016-2021)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Type 2 Diabetes Medication Product Solution and Service
    Table 27. Date of Enter into Type 2 Diabetes Medication Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Type 2 Diabetes Medication Market Size by Type (2016-2021) (US$ Million)
    Table 30. Global Type 2 Diabetes Medication Revenue Market Share by Type (2016-2021)
    Table 31. Global Type 2 Diabetes Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 32. Global Type 2 Diabetes Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 33. Global Type 2 Diabetes Medication Market Size Share by Application (2016-2021) & (US$ Million)
    Table 34. Global Type 2 Diabetes Medication Revenue Market Share by Application (2016-2021)
    Table 35. Global Type 2 Diabetes Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 36. Global Type 2 Diabetes Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 37. North America Type 2 Diabetes Medication Market Size by Type (2016-2021) (US$ Million)
    Table 38. North America Type 2 Diabetes Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 39. North America Type 2 Diabetes Medication Market Size by Application (2016-2021) (US$ Million)
    Table 40. North America Type 2 Diabetes Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 41. North America Type 2 Diabetes Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. North America Type 2 Diabetes Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Europe Type 2 Diabetes Medication Market Size by Type (2016-2021) (US$ Million)
    Table 44. Europe Type 2 Diabetes Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Europe Type 2 Diabetes Medication Market Size by Application (2016-2021) (US$ Million)
    Table 46. Europe Type 2 Diabetes Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Europe Type 2 Diabetes Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 48. Europe Type 2 Diabetes Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 49. Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2016-2021) & (US$ Million) 
    Table 54. Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2022-2027) & (US$ Million) 
    Table 55. Latin America Type 2 Diabetes Medication Market Size by Type (2016-2021) (US$ Million)
    Table 56. Latin America Type 2 Diabetes Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Latin America Type 2 Diabetes Medication Market Size by Application (2016-2021) (US$ Million)
    Table 58. Latin America Type 2 Diabetes Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Latin America Type 2 Diabetes Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Latin America Type 2 Diabetes Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2016-2021) & (US$ Million) 
    Table 66. Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2022-2027) & (US$ Million) 
    Table 67. AstraZeneca Company Details
    Table 68. AstraZeneca Business Overview
    Table 69. AstraZeneca Type 2 Diabetes Medication Product
    Table 70. AstraZeneca Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 71. AstraZeneca Recent Development
    Table 72. Novartis Company Details
    Table 73. Novartis Business Overview
    Table 74. Novartis Type 2 Diabetes Medication Product
    Table 75. Novartis Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 76. Novartis Recent Development
    Table 77. Novo Nordisk Company Details
    Table 78. Novo Nordisk Business Overview
    Table 79. Novo Nordisk Type 2 Diabetes Medication Product
    Table 80. Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 81. Novo Nordisk Recent Development
    Table 82. Johnson & Johnson Company Details
    Table 83. Johnson & Johnson Business Overview
    Table 84. Johnson & Johnson Type 2 Diabetes Medication Product
    Table 85. Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 86. Johnson & Johnson Recent Development
    Table 87. Boehringer Ingelheim Company Details
    Table 88. Boehringer Ingelheim Business Overview
    Table 89. Boehringer Ingelheim Type 2 Diabetes Medication Product
    Table 90. Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 91. Boehringer Ingelheim Recent Development
    Table 92. Bristol-Myers Squibb Company Details
    Table 93. Bristol-Myers Squibb Business Overview
    Table 94. Bristol-Myers Squibb Type 2 Diabetes Medication Product
    Table 95. Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 96. Bristol-Myers Squibb Recent Development
    Table 97. Eli Lilly Company Details
    Table 98. Eli Lilly Business Overview
    Table 99. Eli Lilly Type 2 Diabetes Medication Product
    Table 100. Eli Lilly Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 101. Eli Lilly Recent Development
    Table 102. Merck Company Details
    Table 103. Merck Business Overview
    Table 104. Merck Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 105. Merck Recent Development
    Table 106. Sanofi Company Details
    Table 107. Sanofi Business Overview
    Table 108. Sanofi Type 2 Diabetes Medication Product
    Table 109. Sanofi Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 110. Sanofi Recent Development
    Table 111. Pfizer Company Details
    Table 112. Pfizer Business Overview
    Table 113. Pfizer Type 2 Diabetes Medication Product
    Table 114. Pfizer Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 115. Pfizer Recent Development
    Table 116. Astellas Pharma Company Details
    Table 117. Astellas Pharma Business Overview
    Table 118. Astellas Pharma Type 2 Diabetes Medication Product
    Table 119. Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 120. Astellas Pharma Recent Development
    Table 121. Daiichi Sankyo Company Details
    Table 122. Daiichi Sankyo Business Overview
    Table 123. Daiichi Sankyo Type 2 Diabetes Medication Product
    Table 124. Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 125. Daiichi Sankyo Recent Development
    Table 126. Biocon Company Details
    Table 127. Biocon Business Overview
    Table 128. Biocon Type 2 Diabetes Medication Product
    Table 129. Biocon Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 130. Biocon Recent Development
    Table 131. Glenmark Company Details
    Table 132. Glenmark Business Overview
    Table 133. Glenmark Type 2 Diabetes Medication Product
    Table 134. Glenmark Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 135. Glenmark Recent Development
    Table 136. Bayer AG Company Details
    Table 137. Bayer AG Business Overview
    Table 138. Bayer AG Type 2 Diabetes Medication Product
    Table 139. Bayer AG Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 140. Bayer AG Recent Development
    Table 141. Takeda Company Details
    Table 142. Takeda Business Overview
    Table 143. Takeda Type 2 Diabetes Medication Product
    Table 144. Takeda Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 145. Takeda Recent Development
    Table 146. Sun pharma Company Details
    Table 147. Sun pharma Business Overview
    Table 148. Sun pharma Type 2 Diabetes Medication Product
    Table 149. Sun pharma Revenue in Type 2 Diabetes Medication Business (2016-2021) & (US$ Million)
    Table 150. Sun pharma Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Type 2 Diabetes Medication Market Share by Type: 2020 VS 2027
    Figure 2. Biguanides Features
    Figure 3. Sulphonylureas Features
    Figure 4. Thiazolidinediones Features
    Figure 5. Alpha-glucosidase Inhibitors Features
    Figure 6. DPP-4 Inhibitors Features
    Figure 7. GLP-1 Receptor Agonists Features
    Figure 8. SGLT-2 Inhibitors Features
    Figure 9. Insulins Features
    Figure 10. Global Type 2 Diabetes Medication Market Share by Application: 2020 VS 2027
    Figure 11. Hospital Pharmacies Case Studies
    Figure 12. Retail Pharmacies Case Studies
    Figure 13. Online Pharmacies Case Studies
    Figure 14. Type 2 Diabetes Medication Report Years Considered
    Figure 15. Global Type 2 Diabetes Medication Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Type 2 Diabetes Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Type 2 Diabetes Medication Market Share by Regions: 2020 VS 2027
    Figure 18. Global Type 2 Diabetes Medication Market Share by Regions (2022-2027)
    Figure 19. Global Type 2 Diabetes Medication Market Share by Players in 2020
    Figure 20. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 2 Diabetes Medication as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medication Revenue in 2020
    Figure 22. Global Type 2 Diabetes Medication Revenue Market Share by Type (2016-2021)
    Figure 23. Global Type 2 Diabetes Medication Revenue Market Share by Type (2022-2027)
    Figure 24. North America Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Type 2 Diabetes Medication Market Share by Type (2016-2027)
    Figure 26. North America Type 2 Diabetes Medication Market Share by Application (2016-2027)
    Figure 27. North America Type 2 Diabetes Medication Market Share by Country (2016-2027)
    Figure 28. United States Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Type 2 Diabetes Medication Market Share by Type (2016-2027)
    Figure 32. Europe Type 2 Diabetes Medication Market Share by Application (2016-2027)
    Figure 33. Europe Type 2 Diabetes Medication Market Share by Country (2016-2027)
    Figure 34. Germany Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Type 2 Diabetes Medication Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Type 2 Diabetes Medication Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Type 2 Diabetes Medication Market Share by Region (2016-2027)
    Figure 44. China Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Type 2 Diabetes Medication Market Share by Type (2016-2027)
    Figure 52. Latin America Type 2 Diabetes Medication Market Share by Application (2016-2027)
    Figure 53. Latin America Type 2 Diabetes Medication Market Share by Country (2016-2027)
    Figure 54. Mexico Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Type 2 Diabetes Medication Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Type 2 Diabetes Medication Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Type 2 Diabetes Medication Market Share by Country (2016-2027)
    Figure 60. Turkey Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Type 2 Diabetes Medication Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 64. Novartis Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 65. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 66. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 67. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 69. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 70. Merck Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 71. Sanofi Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 72. Pfizer Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 73. Astellas Pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 74. Daiichi Sankyo Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 75. Biocon Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 76. Glenmark Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 77. Bayer AG Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 78. Takeda Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 79. Sun pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer
Astellas Pharma
Daiichi Sankyo
Biocon
Glenmark
Bayer AG
Takeda
Sun pharma
Frequently Asked Questions
Type 2 Diabetes Medication report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Type 2 Diabetes Medication report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Type 2 Diabetes Medication report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports